Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Secretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry.

Choi J, Kim D, Koo JS.

Int J Surg Pathol. 2012 Aug;20(4):367-72. doi: 10.1177/1066896912440506. Epub 2012 Apr 4.

PMID:
22491513
[PubMed - indexed for MEDLINE]
2.

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.

Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C.

Am J Surg Pathol. 2001 Aug;25(8):1054-60.

PMID:
11474290
[PubMed - indexed for MEDLINE]
3.

p63 expression in benign and malignant breast lesions.

Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ.

Histol Histopathol. 2004 Apr;19(2):465-71.

PMID:
15024707
[PubMed - indexed for MEDLINE]
4.

Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.

Bratthauer GL, Saenger JS, Strauss BL.

Histopathology. 2005 Dec;47(6):611-6.

PMID:
16324199
[PubMed - indexed for MEDLINE]
5.

CD24 expression has a prognostic impact in breast carcinoma.

Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E.

Pathol Res Pract. 2009;205(8):524-33. doi: 10.1016/j.prp.2009.01.008. Epub 2009 Feb 24.

PMID:
19243896
[PubMed - indexed for MEDLINE]
6.

Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.

Martin SE, Temm CJ, Goheen MP, Ulbright TM, Hattab EM.

Mod Pathol. 2011 Oct;24(10):1320-6. doi: 10.1038/modpathol.2011.89. Epub 2011 May 27.

PMID:
21623385
[PubMed - indexed for MEDLINE]
Free Article
7.

Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.

Werling RW, Hwang H, Yaziji H, Gown AM.

Am J Surg Pathol. 2003 Jan;27(1):82-90.

PMID:
12502930
[PubMed - indexed for MEDLINE]
8.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

PMID:
16698948
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.

Kawaguchi K, Shin SJ.

Am J Surg Pathol. 2012 Jul;36(7):1009-20. doi: 10.1097/PAS.0b013e31824e0f90.

PMID:
22446941
[PubMed - indexed for MEDLINE]
10.

Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.

Zheng HC, Saito H, Masuda S, Wang ZG, Takano Y.

Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):459-65. doi: 10.1097/PAI.0b013e3181640bb1.

PMID:
18665036
[PubMed - indexed for MEDLINE]
11.

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Grunewald TG, Kammerer U, Kapp M, Eck M, Dietl J, Butt E, Honig A.

BMC Cancer. 2007 Oct 23;7:198.

PMID:
17956604
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.

Breast Cancer Res Treat. 2006 Jun;97(3):275-83. Epub 2005 Dec 13.

PMID:
16344916
[PubMed - indexed for MEDLINE]
13.

Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.

Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB.

J Pathol. 2005 Apr;205(5):585-91.

PMID:
15776477
[PubMed - indexed for MEDLINE]
14.

Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.

Xu Z, Wang W, Deng CX, Man YG.

Int J Biol Sci. 2009;5(1):82-96. Epub 2009 Jan 9.

PMID:
19173015
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.

Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y.

Hum Pathol. 2011 Mar;42(3):424-33. doi: 10.1016/j.humpath.2009.12.018. Epub 2010 Dec 28.

PMID:
21193223
[PubMed - indexed for MEDLINE]
16.

Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.

Rabban JT, Swain RS, Zaloudek CJ, Chase DR, Chen YY.

Mod Pathol. 2006 Oct;19(10):1351-7. Epub 2006 Jun 30.

PMID:
16810311
[PubMed - indexed for MEDLINE]
Free Article
17.

p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Alvarenga M, Vassallo J.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):71-7.

PMID:
16540734
[PubMed - indexed for MEDLINE]
18.

Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis.

Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, Ogata Y, Nakashima O, Kage M, Yano H.

Jpn J Clin Oncol. 2010 Aug;40(8):781-7. doi: 10.1093/jjco/hyq056. Epub 2010 May 5.

PMID:
20444748
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.

Edwards PC, Bhuiya T, Kelsch RD.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 May;97(5):613-9.

PMID:
15153875
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk